XOLREMDI FDA approval date
The FDA approved XOLREMDI on 26 Apr 2024.
- FDA approval date
- 26 Apr 2024
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as MAVORIXAFOR
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2024-04-26Day | XOLREMDI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA218709", "applicant_as_listed_by_fda": "X4 PHARMS", "brand_names": ["XOLREMDI"], "active_ingredients": ["MAVORIXAFOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240426", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |